Although in-patient and outpatient expenses were not associated with obesity , pharmaceutical expenditures were $ 408 or 87.2 % higher per year ( $ 468 versus $ 876 ) for obese individuals than for nonobese individuals , which reflected poorer health behaviors and health status of obese adults .